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Abstract: We explored (a) the associations between self-reported maternal physical fitness and birth
outcomes; (b) whether self-reported maternal physical fitness (PF) is related to the administration of
oxytocin to induce or stimulate labour. Pregnant women from the GESTAFIT project randomized
controlled trial (n = 117) participated in this prospective longitudinal study. Maternal physical
fitness was assessed through the International Fitness Scale at the 34th gestational week. Maternal
and neonatal birth outcomes and oxytocin administration were collected from the obstetric medical
records. Umbilical arterial and venous cord blood gas were analysed immediately after birth. Self-
reported overall fitness, cardiorespiratory fitness, muscular strength and flexibility were not related
to any maternal and neonatal birth outcomes (all p > 0.05). Greater speed-agility was associated with
a more alkaline arterial (p = 0.04) and venous (p = 0.02) pH in the umbilical cord blood. Women who
were administered oxytocin to induce or stimulate labour reported lower cardiorespiratory fitness
(p = 0.013, Cohen’s d = 0.55; 95% confidence interval (CI): 0.14, 0.93) and flexibility (p = 0.040, Cohen´s
d = 0.51; 95% CI: 0.09, 0.89) compared to women who were not administered oxytocin. Greater
maternal physical fitness during pregnancy could be associated with better neonatal birth outcomes
and lower risk of needing oxytocin administration.
Keywords: umbilical cord blood; maternal health; physical fitness; flexibility; pregnancy outcomes
1. Introduction
Birth and the events that occur during labour may have important implications for
both, the mother and the new born’s future health. Some adverse events could be associated
with natural reasons—such as placental pathologies [1] or iatrogenic causes, as a result of
interventions carried out by health professionals—such as anaesthesia -related problems [2].
In this sense, it is clinically relevant to describe maternal aptitudes that may be related to
an improvement in birth outcomes and a lower risk of iatrogenic injuries during labour.
In relation to this, whereas the effects of exercise on birth outcomes have been broadly
described [3,4], the association of maternal physical fitness (PF) with other important
outcomes, such as duration of the stages of labour and values of umbilical cord blood
gases, continue to be scarce and only its relationship with some maternal and foetal health
markers has been previously suggested [5–7].
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Moreover, it has been proposed in the last years to avoid interventions that are not
necessary during labour [8], such as the administration of oxytocin, commonly used to
increase or improve uterine dynamics [9]. It is noteworthy that the use of exogenous
oxytocin during labour has been previously associated with an increased risk of uterine
hyperactivity and postpartum haemorrhage, pathologies of foetal heart rate, increased
morbidity and neonatal mortality and breast feeding problems, among others [10,11].
In order to study the associations of maternal PF with different health outcomes,
PF can be measured in a precise way through objective tests [12,13]. However, this kind
of tests requires a lot of time to carry them out, so the development of measuring tools
adapted to the health professionals—who usually have less than five mins of consultation
time [14] is mandatory. For this purpose, the International FItness Scale (IFIS) could be
a validated, straightforward and handy clinical non-objective tool for assessing PF in
pregnant women [15].
Since pregnancy and labour events have important implications for maternal and
foetal health, it is of clinical interest to know which PF components may be potentially
related to better birth outcomes and with a lower risk than administered oxytocin to induce
or stimulate labour. Therefore, the objectives of the present study are: (i) To explore the
associations between self-reported maternal PF during late pregnancy and birth outcomes;
and (ii) to study whether self-reported maternal PF during late pregnancy is related to the
administration of oxytocin to induce or stimulate labour.
2. Materials and Methods
2.1. Study Design and Participants
This study is part of the GESTAFIT project randomized controlled trial. Briefly, the in-
clusion criteria were healthy women aged 25–40 years old, with a normal pregnancy course,
who signed the informed consent. Some of the exclusion criteria were high-risk obstetric
pregnancies, foetal malformations and maternal malnutrition, among others (Supplemen-
tary Material, Table S1). Detailed procedures have been previously published [16]. At the
12th gestational week (early pregnancy), a total of 384 pregnant women were informed
about the project during their first visit to the gynaecologist at the ‘San Cecilio’ University
Hospital and the ‘Virgen de las Nieves’ University Hospital in Granada (southern Spain).
Finally, 159 women signed an informed consent which included the study aims, evaluation
and procedures.
The Clinical Research Ethics Committee of Granada, Regional Government of An-
dalusia, Spain approved the GESTAFIT study (code: GESTAFIT-0448-N-15, approved on
19 May 2015).
2.2. Procedures
The first evaluation of the study was carried out during the 16th gestational week
(±2 weeks). Women completed a self-reported questionnaire on socio-demographic and
clinical characteristics. Moreover, height and weight were assessed. At the 34th gestational
week (±2 weeks), the second assessment of height and weight was conducted, and self-
reported PF was assessed after being informed by the research team about how to properly
fill it. Obstetric and gynaecological histories and birth outcomes were collected through
the Documento de Salud de la Embarazada (from now on, Pregnancy Health Document, its
translation into English) and digital medical records.
2.3. Sociodemographic and Clinical Data
A self-reported questionnaire was used to assess sociodemographic (age, parity, num-
ber of children and educational and working statuses) and clinical (suffering or have
suffered specific diseases) data. The research team was present at all times for any explana-
tions or instructions required by the participants.
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2.4. Anthropometry and Body Composition
Height and weight were measured using a stadiometer (Seca 22, Hamburg, Germany)
and a scale (InBody R20; Biospace, Seoul, Korea), respectively. Body mass index (BMI) was
calculated as: weight (kg)/height (m2).
2.5. Obstetric History
Regional Government of Andalusia provides the Pregnancy Health Document to all
pregnant women. It contains obstetric and medical data that were collected for the present
study. In this way, information about previous pregnancies and births and gynaecological
antecedents were obtained. The gestational age was calculated by the date of the last
menstruation, corrected for cycles of 28 days and subsequently corrected by ultrasound, if
needed [17].
2.6. Birth Outcomes
All data related to the type of birth (eutocic, instrumental, or caesarean), gestational
week at birth, use of epidural analgesia, length of labour, sex of the neonate, neonatal
weight and Apgar test were obtained from perinatal obstetric records (partogram) collected
from the Hospital.
2.6.1. Umbilical Cord Blood Gas Analysis
Between the second and the third min of the neonate’s life, a trained midwife per-
formed a double clamping of the umbilical cord, with a minimum distance between both
clamps of 10 cm for the umbilical cord blood sampling. A pre-heparinized 1 mL syringe
was used for the blood extraction. Blood samples were taken from both, umbilical artery
and vein. Partial pressure of carbon dioxide (PCO2), partial pressure of oxygen (PO2),
oxygen saturation and pH were analysed using a blood analyser (GEM Premier 4000,
Instrumentation Laboratory, Bedford, MA, USA).
2.6.2. Oxytocin Administration before or during Labour
Information about the use of oxytocin during labour was collected from the partogram.
In this document, midwives usually record whether oxytocin is administered or not, but the
dose and administration time are not frequently collected, so these data were not assessed
in the present study. Moreover, we consider that oxytocin was administered both, by
induction of labour (for clinical reasons such us post-term pregnancy, premature rupture of
membranes or preeclampsia, among others) and uterine stimulation during the labour, but
we did not take into account the administration of this drug during placenta delivery.
2.7. Physical Fitness
Physical fitness was self-reported with the International FItness Scale (IFIS), which
is composed of five Likert-scale questions from 1 (very poor) to 5 (very good) asking the
participants about their perceived overall PF, cardiorespiratory fitness (CRF), muscular
strength (MS), speed-agility and flexibility in comparison with their counterparts. The
participants rated their PF components as ‘very poor’, ‘poor’, ‘average’, ‘good’ and ‘very
good’ [18]. The higher score indicates greater PF that the participant experiences. This
questionnaire is available in different languages at http://profith.ugr.es/IFIS (accessed on
20 January 2021).
2.8. Statistical Analyses
All the variables were checked for normality of distribution before the analyses. We
employed descriptive statistics [mean (standard deviation, SD)] for quantitative variables
and number of cases and percentage (%) for categorical variables to describe the baseline
characteristics of the study sample (Table 1). The association of self-reported PF with birth
outcomes was assessed with Pearson´s partial correlations after adjusting for maternal
age, parity, maternal BMI and exercise intervention (Table 2). The associations of PF levels
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with duration of first and second labour stages, as well as neonatal birth outcomes were
additionally adjusted for epidural analgesia, except for the variable ‘birthweight’ which
was only further adjusted for gestational age. Since some variables (adherence to the
Mediterranean diet, gestational age at birth, birthweight, onset of labour and instrumental
birth) previously showed slight relationship with the study variables, we performed
secondary analyses to assess their role as potential confounders.
Table 1. Sociodemographic and clinical characteristic of the study sample (n = 117).
Maternal Outcomes n Mean (SD)
Age, years 117 33.1 (4.5)
Body mass index at 16th gestational week, Kg/m2 117 24.6 (4.1)
n (%)
Living with a partner 115 (98.3)
Educational status 117
Primary or high-school 24 (20.6)
Specialized training 19 (16.2)
University degree 74 (63.2)
Working status 117
Homework/unemployed 34 (29.1)
Partial-time employed/student 34 (29.1)
Full-time employed 49 (41.8)
Self-reported Physical Fitness (0–5)
34th gestational week 117
Overall physical fitness 3.3 (0.7)
Cardiorespiratory fitness 2.6 (0.8)
Muscular strength 3.3 (0.7)
Speed-agility 3.0 (0.7)
Flexibility 3.1 (1.0)
Type of birth 110





Caesarean section 25 (22.7)
Oxytocin administered during labor, n % 30 (27.8)
Birth place 115
Public Hospital 108 (93.9)






Sex (female, n (%)) 55 (50)
Gestational age at birth, wk 39.5 (1.2)
Birthweight, g 3338.5 (428.7)
Apgar Test 1 min 8.6 (1.1)
Apgar Test 5 min 9.6 (0.7)
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Table 1. Cont.
Maternal Outcomes n Mean (SD)
Umbilical Cord blood Gas
Arterial pH 80 7.2 (0.07)
Arterial Partial Pressure CO2, mmHg 75 51.6 (10.7)
Arterial Partial Pressure O2, mmHg 72 19.5 (9.4)
Arterial O2 saturation, % 69 34.6 (22.8)
Venous pH 93 7.3 (0.1)
Venous Partial Pressure CO2, mmHg 89 39.7 (7.7)
Venous Partial Pressure O2, mmHg 80 26.2 (8.5)
Venous O2 saturation, % 77 54.7 (18.0)
Values shown as mean (SD, standard deviation) unless otherwise indicated; CO2, carbon dioxide; O2, oxygen.
An analysis of the covariance (ANCOVA) was employed to explore the differences
in self-reported PF components between women who were administered versus women
who were not administered oxytocin during labour (Table 3), and it was adjusted for
maternal age, parity, maternal BMI, epidural analgesia and birthplace (public or private
hospital). Elective caesarean sections (elected because of feet or buttocks coming first,
n = 6) were excluded from the present analyses. Finally, like in the GESTAFIT project [16],
a concurrent physical exercise program was performed, we have also adjusted all analyses
for the exercise intervention (control or intervention). Furthermore, standardised effect size
statistics were estimated in all the comparisons through Cohen’s d and its exact confidence
interval (CI). The effect size was interpreted as small (∼0.2), medium (∼0.5) or large (∼0.8
or greater) [19]. The statistical analyses were conducted with the Statistical Package for
Social Sciences (IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY, USA: IBM
Corp). The statistical significance was set at p < 0.05.
3. Results
From the 159 women who signed the informed consent and met the inclusion crite-
ria, 158 had complete sociodemographic data. The final sample size was composed of
117 Caucasian pregnant women (age 33.1 ± 4.5 years old, BMI 24.6 ± 4.1 kg/m2) who
presented valid data for the present analyses (Figure 1).
Sociodemographic and clinical data, and self-reported PF components of the study
sample are shown in Table 1. Most of the participants lived with their partners (98.3%) and
more than a half of them had university degrees (63.2%). Broadly, participants rated their
PF levels as ‘average’, except for CRF, which was classified as ‘poor’, compared to their peers.
Regarding birth outcomes, 77.3% had vaginal births and nearly a quarter had caesarean
sections. Around 58% of participants were nulliparous and 27.8% were administered
oxytocin before or during the labour. They gave birth around the 40th gestational week
and neonates had a birthweight average of 3338 ± 428 g.
Pearson´s partial correlations of self-reported PF levels at the 34th gestational week
with pregnancy and neonatal birth outcomes are shown in Table 2. After adjusting for
potential confounders, speed-agility showed a significant positive association with arterial
(p = 0.04) and venous cord blood pH (p = 0.02). Greater overall PF and MS showed
some evidence of borderline statistical significance with higher cord blood venous pH
(both, p < 0.100). Nevertheless, flexibility was not associated with any birth outcomes (all,
p > 0.05). Finally, maternal outcomes, birthweight, Apgar test and partial pressure of CO2,
O2 and oxygen saturation in both umbilical blood vessels were not associated with any
self-reported PF component (all, p > 0.05).




Figure 1. Flow diagram of study participants. 
  
Figure 1. Flow diagram of study participants.









Week of gestation (at birth) (n = 101) 0.018 0.083 0.087 0.070 0.014
Duration of first stage of labour a (n = 63) −0.014 −0.063 0.013 0.061 0.085
Duration of second stage of labour a (n = 69) −0.021 −0.069 −0.040 0.103 0.152









Birthweight (n = 101) −0.009 −0.112 0.053 0.070 0.003
Apgar Test 1 min a (n = 95) 0.101 0.075 −0.072 0.034 −0.048
Apgar Test 5 min a (n = 95) −0.081 −0.042 0.002 −0.107 −0.177
Cord blood arterial pH a (n = 69) 0.109 0.056 0.154 0.232 * −0.017
Cord blood arterial partial pressure of CO2 a (n = 65) −0.044 0.005 −0.094 −0.165 0.049
Cord blood arterial partial pressure of O2 a (n = 62) −0.006 −0.156 0.042 −0.020 −0.102
Cord blood arterial oxygen saturation a (n = 59) −0.051 −0.110 0.045 −0.023 −0.130
Cord blood venous pH a (n = 81) 0.207 0.091 0.214 0.239 * −0.028
Cord blood venous partial pressure of CO2 a (n = 78) −0.074 0.024 −0.183 −0.130 0.040
Cord blood venous partial pressure of O2 a (n = 69) 0.094 −0.062 0.130 0.133 0.034
Cord blood venous O2 saturation a (n = 66) 0.127 0.011 0.108 0.033 0.109
O2, Oxygen; CO2, carbon dioxide. Model adjusted for maternal age, parity, maternal body mass index at the 16th gestational week, and the
exercise intervention. Maternal birth outcomes were additionally adjusted for birthweight. a Model additionally adjusted for epidural
analgesia. Birthweight was further adjusted for gestational age. * p < 0.05.
Differences on self-reported PF levels at the 34th gestational week of the study partici-
pants by oxytocin administration before or during labour are shown in Table 3. Women
who were not administered oxytocin showed greater CRF compared to women who needed
oxytocin (of 2.73 ± 0.7 versus 2.32 ± 0.8, respectively, p = 0.044 for the unadjusted model
and p = 0.013 for the adjusted model, Cohen´s d = 0.55; 95% CI: 0.14, 0.93). Greater flexi-
bility was shown in women who were not given oxytocin compared to women who were
given oxytocin (of 3.27 ± 1.1 versus 2.75 ± 0.9, respectively, p = 0.013 for the unadjusted
model and p = 0.040 for the adjusted model, Cohen´s d = 0.51; 95% CI: 0.09, 0.89). No
significant differences were found in self-reported overall fitness, MS and speed-agility
between women who were not administered and those who were administered oxytocin
during the labour (all, p > 0.05).
Table 3. Differences in the self-reported physical fitness components of the pregnant women at the 34th gestational week by
oxytocin administration before or during labour.
Oxytocin Was Not








Overall fitness 3.38 (0.8) 3.25 (0.7) 0.067 0.348 0.16 (−0.22, 0.55)
Cardiorespiratory fitness 2.73 (0.7) 2.32 (0.8) 0.044 0.013 0.55 (0.14, 0.93)
Muscular strength 3.27 (0.7) 3.29 (0.7) 0.966 0.982 −0.014 (−0.37, 0.35)
Speed-agility 2.95 (0.7) 2.96 (0.6) 0.967 0.728 0.0 (−0.51, 0.37)
Flexibility 3.27 (1.1) 2.75 (0.9) 0.013 0.040 0.51 (0.09, 0.89)
CI, Confidence interval. * Model adjusted for maternal age, parity, maternal body mass index at the 16th gestational week, exercise
intervention, epidural analgesia and birthplace. Values shown as mean (standard deviation).
4. Discussion
This study explored the association of maternal self-reported PF levels in late preg-
nancy with birth outcomes, and the use of oxytocin during the labour. One of the major
findings of the present study is that those women who required oxytocin during labour
showed lower self-reported CRF and flexibility in late pregnancy. Moreover, greater ma-
ternal speed-agility was associated with a more alkaline pH in both, umbilical artery
and vein.
In this study, no association was found between maternal gestational week at birth,
and duration of first and second stages of labour with PF components. As far as we
know, there are no previous studies analysing the influence of self-reported maternal PF
on birth outcomes, so the reliable comparison of the present findings is extremely diffi-
cult. Nevertheless, our results do not concur with those described by Kardel et al. [20],
who observed a relationship of CRF (objectively measured through maximum oxygen
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consumption) at the 35–37th gestational weeks, with shorter labours in 40 nulliparous
women. It should be taken into account that the mean CRF of our sample was re-
ported as ‘poor’, and it is possible that the shortening of labour was related to slightly
higher values of this PF dimension. On the other hand, two studies have previously
found a positive association of maternal MS with birthweight in two samples of 95 and
65 healthy pregnant women respectively [5,21], but in both cases the importance of the
second trimester of pregnancy is highlighted for this association to be positive. It is possible
that this finding was not found in late pregnancy, since in the third trimester maternal MS
tends to decrease [5].
Notwithstanding, we found that greater self-reported speed-agility was related to
more alkaline pH in both umbilical vessels. Preventing foetal acidosis is essential for the
future health of the new born, since arterial pH under 7.20 has been related to an increased
number of neonatal pathologies and deaths [22]. During labour, many women experience
fatigue, which is associated with both, physical and mental discomfort [23]. For this reason,
we hypothesise that women who feel themselves more agile might be more likely to have
an active labour with greater changes of body position, that leads to an improvement of
birth outcomes [24,25]. These results should be interpreted with caution and more studies
are needed to confirm these associations.
After adjusting for substantial potential confounders, we found that women who were
administered oxytocin during labour had lower CRF and flexibility than women who did
not need this drug. CRF is related to the ability of the circulatory and respiratory systems
to supply oxygen to the tissues and to eliminate fatigue products [26] and it has been
positively associated with endogenous oxytocin levels in pregnant women [27]. Moreover,
labour is a strenuous process that often has a long duration and usually produces a huge
physiological fatigue [23]. In this sense, it has been described that fatigue during labour
is related to alterations in uterine dynamics [28], which is one of the indications for the
administration of synthetic oxytocin [29]. Although more studies are needed to confirm
this, it is possible that women with greater CRF experienced less fatigue during labour
and, therefore, showed a better uterine dynamic, so that they did not need exogenous
oxytocin administration.
Regarding flexibility, no previous studies have associated this PF dimension with the
use of oxytocin. A possible explanation to our findings could be that women with greater
self-reported flexibility during pregnancy could also have higher levels of relaxin, which is
naturally increased during pregnancy [30]. Thus, as this hormone has vasodilator effects
when acting on its receptors in the uterine artery [31], it is possible that the increase in
uterine vascularization improves its dynamics during labour. Finally, it seems that high
levels of relaxin could also have an important implication in the appearance of uterine
contractions during pregnancy [32,33], although the mechanisms are not fully understood
yet [34].
According to the data of the Spanish Ministry of Health, Social Services and Equality,
the prevalence of the use of exogenous oxytocin during spontaneous labour in Spanish
public hospitals is 53%, much higher than the recommended standard of 5–10% [35].
Among the women who presented valid data for the analysis of differences in PF by
oxytocin administration, almost one in four had been provided with this hormone during
labour, so these figures are still higher than recommended. Synthetic oxytocin is widely
used as a treatment for dystocia of uterine dynamics [29] and as a method to induce the
labour [36]. However, its use has been related to an increased risk of uterine hyperactivity,
abnormalities in the foetal heart rate and postpartum haemorrhage [10]. In addition, other
studies have associated the use of oxytocin during birth with sucking problems of the
neonate and early cessation of breast feeding [37], among other neonatal problems [38].
Altogether, the findings of the present study are clinically relevant. The IFIS could be
employed as an easy and quick clinical tool by midwives and other health professionals
to assess women who should receive health education, in order to improve their PF and
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avoid, in this way, the potential need to be administered oxytocin before or during the
future labour. Nevertheless, more studies are needed to confirm the findings of our study.
Some limitations of the present study should be highlighted. First, the associations
found cannot be explained by a direct causality, since the results are derived from a cross-
sectional study design. Therefore, further research is warranted in order to address the
causality of our findings. Second, although subjective measures tend to overestimate some
dimensions, the IFIS has been validated in the pregnant population [15].
Key strength of our methodology is that the sample size employed was relatively
large compared to other studies performed on pregnant women. Further strengths include
the gas measurement of the umbilical artery blood is considered a gold standard, and
the extraction of paired samples (in both umbilical vessels) allowed a more accurate
interpretation of the results.
5. Conclusions
Overall, in late pregnancy, we found that greater self-reported speed-agility was
related to more alkaline pH in arterial and venous umbilical cord blood gas. Moreover,
women who were administered oxytocin during labour reported lower self-reported CRF
and flexibility during late pregnancy than women who were not given this drug, which
indicates that greater levels in both PF components could be related to a decrease of the
risk of having an induced or stimulated labour with oxytocin.
Assessing PF during pregnancy and encouraging women to improve it by performing
physical activity and exercise could have important implications for the well-being and
health of women and their children. In order to decrease the already high rates of oxytocin
administration before or during labour in Spain, interventions focused on improving
physiological births should be promoted.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/ijerph18158201/s1, Supplementary Table S1: Inclusion and exclusion criteria in the GESTAFIT
project.
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